|
1.
Share Success: Letters From Readers
Letter
I: From Mark B.
Received
at Customer Service Aug 3 at 9:12 PM
(Unedited)
I have been a customer of EZorb Calcium for 3 months and my heel Plantar Bone Spur pain is gone. I suffered with pain for 5 years with numerous injections and was facing surgery when I found your web-site. Thank you.
Letter II: From Linda L.
Received
at Testimonial Submit Form Monday, May 07, 2018 at 20:35:03
(Unedited)
Hi, my name is Dorothy P. I've been taking Ezorb Powder for over an year.
I had been diagnosed with osteoporosis. My doctor wanted to give me pills or possible a shot. I told him in 2017 that I had come across EZORB and I was going to take the powders. He said well, I guess you can try that, then when you return in 2018, we
can start the shot.
I explained to him that pills and shots make your bones appear to be larger however, they are dead bones. With EZORB my bone would be larger with the difference they will be live bones. He looked at me like yeah right!
Well, I returned in 2018 with my bone scan in hand smiling from ear to ear. He was amazed I no longer was in the stage of having osteoporosis. He ask me if I would share my info on the ezorb, I did, I carried him literature on ezorb.
He said I never would have thought that it would work. But! He said he was going to tell his other patients about it.
I'm happy and I want to sincerely thank you for making such a wonderful product. I would be happy to speak to any one that would like to discuss or know just how great it works. I'm 77 will be 78 in september 2018.
Dorothy P. -SAVANNAH GEORGIA
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: High Blood Eosinophilia Level May Indicate Lung Function Decline
High blood eosinophil counts are associated with airflow obstruction and lung function decline in patients with asthma, but also in people without respiratory symptoms, population-based study findings show.
Participants with average blood eosinophil counts above 0.4 x 109 L between the ages of 21 and 38 years had declines in the ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) and FEV1 that were 1.8% and 3.4% greater, respectively, than those of individuals with lower counts (p=0.001 in both cases).
The declines in these spirometry measures "were of a similar magnitude to the declines observed among those who smoked 10 pack-years or more over the same time," Robert Hancox (University of Otago, Dunedin, New Zealand) and co-researchers note.
Patients with asthma had higher blood eosinophil counts than individuals without asthma. Among 81 asthma patients who had eosinophil counts measures at all four assessments (ages 21, 26, 32, and 38 years), the average count was 0.25 x 109 L versus 0.17 x 109 L for the 96 individuals without asthma (p lt 0.001). And 17% of asthma patients had average eosinophil counts above the 0.40 x 109 L cutoff across all four tests versus 6% of those without asthma (p lt 0.001).
Yet the degree of decline in FEV1/FVC associated with increasing eosinophil count was similar for individuals with and without asthma, at 5.4% and 4.7% per 1 x 109 L, respectively, and significant in both cases (p lt 0.001 and p=0.028, respectively). The associated decline in FEV1 was also similar between the two groups, at 7.0% per 1 x 109 L for individuals with asthma (p=0.052) and 7.8% per 1 x 109 L for individuals without asthma (p=0.004), with the former association reaching significance after taking into account patients who smoked 10 pack-years or more.
And when comparisons were made between patients with and without wheeze, the findings were largely similar, although associations between eosinophil count and post-bronchodilator measured FEV1/FVC and FEV1 were only significant for patients with wheeze.
The researchers report in the European Respiratory Journal that the associations between eosinophil count and FEV1/FVC and FEV1 were seen both for pre- and post-bronchodilator measurements and were independent of timing of asthma diagnosis (childhood or adulthood), cumulative smoking exposure, and lung function during early adulthood, and unaffected by adjustment for body mass index and atopic sensitization.
"Our findings suggest that long-term eosinophilic airway inflammation may worsen lung function decline and increase the risk for COPD," note Hancox and colleagues.
"This is important because it may be possible to prevent this with treatment."
The researchers add: "We need information from prospective randomized controlled trials to establish whether treating eosinophilic inflammation with inhaled corticosteroids would improve long-term outcomes for lung function in either COPD or asthma."
Original article appeared in 08-05-2018 | Asthma | News | Article.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
